10-Q quarterly report · filed Oct 28, 2026

CONMED Corp (CNMD) Q3 2026 10-Q Quarterly Report

Short answer

CONMED Corp (CNMD) filed its Q3 2026 10-Q quarterly report on Oct 28, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $336M (down 0.7% year over year) with net income of $20M.

Q3 2026 key financials · XBRL

Revenue
$336M
−0.7% YoY · −49.2% QoQ
Net income
$20M
+592.4% YoY · −46.4% QoQ
Operating margin
11.1%
Gross margin
56.4%
EPS (diluted)
$0.65
+622.2% YoY · −46.7% QoQ

Source: XBRL data from the CONMED Corp (CNMD) Q3 2026 10-Q on SEC EDGAR. USD.

CONMED Corp Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $335.6M, down 0.7% YoY from $337.9M
  • Gross margin 56.4% vs 49.2% YoY, operating margin 11.1% vs 3.5%
  • Best segment orthopedic surgery: $148.8M, up 7.7%; worst general surgery: $186.7M, down 6.5%
  • Operating cash flow $100.0M, down from $124.4M; capital expenditures $8.5M vs $14.7M
  • Headwinds: inflation, supply-chain challenges, tariffs and higher variable-rate debt costs; potential cost reductions or refinancing ahead

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other CONMED Corp quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.